Literature DB >> 27407978

Combination Vaccines.

S K Jatana1, Mng Nair2.   

Abstract

Infections are still a leading cause of morbidity and mortality in children under five years of age, most of which can be prevented by vaccination. However, there are too many vaccines to be administered, increasing the cost of immunization and visits to the paediatrician. Combination vaccines can be an answer to these problems till the development of a single vaccine containing all the possible antigens. Researchers are aiming at development of an ideal vaccine, which can be given orally at birth, has negligible side effects, is heat stable and is affordable to all the parents.

Entities:  

Keywords:  Combination vaccines; Immunization; Infections

Year:  2011        PMID: 27407978      PMCID: PMC4925373          DOI: 10.1016/S0377-1237(07)80067-0

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  23 in total

1.  A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults.

Authors:  R W Joines; M Blatter; B Abraham; F Xie; N De Clercq; Y Baine; K S Reisinger; A Kuhnen; D L Parenti
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

2.  Vaccines administered simultaneously: directions for new combination vaccines based on an historical review of the literature.

Authors:  Mark A Fletcher; Pascal Fabre; Henri Debois; Pierre Saliou
Journal:  Int J Infect Dis       Date:  2004-11       Impact factor: 3.623

3.  Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.

Authors:  S A Halperin; J King; B Law; E Mills; P Willems
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

4.  Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Hib-HB Vaccine Study Group.

Authors:  D J West; T M Hesley; L C Jonas; L K Feeley; S R Bird; P Burke; J C Sadoff
Journal:  Pediatr Infect Dis J       Date:  1997-06       Impact factor: 2.129

5.  Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.

Authors:  C J White; D Stinson; B Staehle; I Cho; H Matthews; A Ngai; P Keller; J Eiden; B Kuter
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

6.  Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany.

Authors:  Helen Kalies; Thomas Verstraeten; Veit Grote; Nicole Meyer; Anette Siedler; Heinz-Josef Schmitt; Thomas Breuer; Lawrence H Moulton; Rüdiger von Kries
Journal:  Pediatr Infect Dis J       Date:  2004-10       Impact factor: 2.129

7.  Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV Combination vaccine co-administered with a Hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age.

Authors:  Giovanni Gabutti; Fred Zepp; Lode Schuerman; Pietro Dentico; Francesco Bamfi; Renato Soncini; Peter Habermehl; Markus Knuf; Pietro Crovari
Journal:  Scand J Infect Dis       Date:  2004

8.  Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine.

Authors:  T Barington; A Gyhrs; K Kristensen; C Heilmann
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

Review 9.  DTPa-HBV-IPV/Hib vaccine (Infanrix hexa).

Authors:  Monique P Curran; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Combination vaccines for diphtheria, tetanus, pertussis, and Haemophilus influenzae type b.

Authors:  P R Paradiso
Journal:  Ann N Y Acad Sci       Date:  1995-05-31       Impact factor: 5.691

View more
  1 in total

1.  Adsorption of Toll-Like Receptor 4 Agonist to Alum-Based Tetanus Toxoid Vaccine Dampens Pro-T Helper 2 Activities and Enhances Antibody Responses.

Authors:  Juliana Bortolatto; Luciana Mirotti; Dunia Rodriguez; Eliane Gomes; Momtchilo Russo
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.